ATL II also suppresses the proliferation and induces death of human prostate cancer cells DU145 and LNCaP, and arrests the cell cycle in the G2/M phase through mechanisms that possibly relate to AR inhibition, PIAS1 activation, and inhibition of the JAK2/STAT3 signaling pathway [68]. Here, JAK2 is linked to prostate cancer.